Market Access Strategy for Medical Devices in Europe
Strategic recommendations on the topic of market access pathways for medical devices and IVD tests
Recent news and posts
Specifications for calculating the 2026 Hybrid DRGs adopted in Germany
Hybrid DRG is a new reimbursement mechanism in Germany that was introduced in 2024 to facilitate and incentivize reimbursement for interventional procedures in outpatient (day case/day surgery) settings instead of inpatient.
On July 10, 2025, the National Association of Statutory Health Insurance Physicians (KBV) announced that the extended Evaluation Committee has adopted the framework specifications for calculating Hybrid DRGs for 2026.
As the next step, the selection of procedures approved in April 2025 will now be mapped to Hybrid DRGs. This process, along with the calculation of reimbursement tariffs, will be carried out by the Institute for the Hospital Remuneration System (InEK) and the Institute of the Evaluation Committee.
The final catalog of Hybrid DRGs, including the reimbursement tariffs for 2026, is expected to be published in autumn 2025.
The full details in German can be found here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.